에 대한 최신 뉴스 Sera Prognostics (NASDAQ:SERA) 주식

Sera Prognostics

Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services.

Exclusives

Trading Ideas

SCHD

SERA

매주, ‘벤징가의 스톡 위스퍼 지수(Benzinga&#39;s Stock Whisper Index)&#39;는 독점 데이터(proprietary data)와 패턴 인식의 조합을 사용하여 표면 바로 아래에서 주목을 받을 만한 주식 5종목을 소개한다.

벤징가의 &#39;스톡 위스퍼&#39; 지수: 애질런트, 트레이드 데스크, 리인슈런스, 세라 및 슈왑 ETF

Sera Prognostics, Inc. - Class A Common Stock

Sera Prognostics Inc

Serabi Gold PLC

Nevada Approves Abortion Rights Ballot Measure But Won't Go Into Effect Until 2026

Billionaire entrepreneur Mark Cuban congratulated former President Donald Trump and Tesla Inc. CEO Elon Musk on <a href="https://www.benzinga.com/news/24/11/41766547/trump-gives-victory-speech-in-florida-as-winning-pennsylvania-puts-him-at-brink-of-victory-vows-to-f">their potential victory</a>, even before the final election results are announced.
What Happened: Cuban took to X, formerly Twitter, and acknowledged the probable win of Trump and Musk. 
&#8220;Congrats @realDonaldTrump. You won fair and&nbsp;square. Congrats to @elonmusk as&nbsp;well. #Godspeed,&#8221; Cuban wrote.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Congrats <a href="https://twitter.com/realDonaldTrump?ref_src=twsrc%5Etfw">@realDonaldTrump</a>. You won fair and square. Congrats to <a href="https://twitter.com/elonmusk?ref_src=twsrc%5Etfw">@elonmusk</a> as well. <a href="https://twitter.com/hashtag/Godspeed?src=hash&amp;ref_src=twsrc%5Etfw">#Godspeed</a>
&mdash; Mark Cuban (@mcuban) <a href="https://twitter.com/mcuban/status/1854046994345382034?ref_src=twsrc%5Etfw">November 6, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/general/politics/24/11/41732623/bakery-that-often-predicts-election-outcomes-has-this-candidate-winning-in-trump-harris-battle-d?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Bakery That Often Predicts Election Outcomes Has This Candidate Winning In Trump, Harris Battle</a>
At the time of Cuban&#8217;s concession, the Associated Press&#8217;s count showed Trump close to securing the presidency, with 267 of the required 270 electoral votes. Trump was also leading in key yet-to-be-decided races, including Michigan and Wisconsin.
Why It Matters: Cuban, who previously <a href="https://www.benzinga.com/startups/24/10/41574981/mark-cuban-questions-why-trump-supporters-stay-silent-on-his-treatment-of-vendors-says-he-will-take">praised Trump in 2015</a> as the &#8220;best thing to happen to politics in a long time,&#8221; has become one of his fiercest critics.
He endorsed Hillary Clinton in the 2016 election and has remained a strong supporter of the Kamala Harris campaign in the current election cycle.
He also <a href="https://www.benzinga.com/news/24/10/41417224/trump-unleashes-scathing-attack-on-former-friend-mark-cuban-after-billionaire-criticizes-ex-presiden">criticized&nbsp;Trump&#8217;s tariff plans</a> that include a 20% blanket tariff on all imports and a 60% levy specifically on Chinese goods. 
Despite their&nbsp;<a href="https://www.benzinga.com/news/24/10/41222696/mark-cuban-recalls-his-love-hate-relations-with-trump-its-not-like-i-dont-like-him-i-just-dont-think">complex relationship</a>, Cuban has maintained business ties with Trump&#8217;s supporters, including a&nbsp;<a href="https://www.benzinga.com/startups/24/11/41750733/this-is-america-mark-cuban-says-justifying-his-business-relationship-with-trumps-100m-megadonor-and">business relationship</a>&nbsp;with Trump&#8217;s $100M megadonor, Miriam Adelson.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/asia/24/11/41722178/if-trump-and-republicans-sweep-dollar-may-climb-7-but-harris-win-could-bring-5-drop-says-jpmorgan?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">If Trump And Republicans Sweep, Dollar May Climb 7% — But Harris Win Could Bring 5% Drop, Says JPMorgan</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Photos courtesy: Shutterstock

News

Politics

Mark Cuban Congratulates Trump, Musk Before The Election Is Called, Says They 'Won Fair And Square'

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.crowdstrike.com%2Fen-us%2F&amp;esheet=54147816&amp;newsitemid=20241106324741&amp;lan=en-US&amp;anchor=CrowdStrike&amp;index=1&amp;md5=15ecc416fff1ecb9f6ea37b9781227b7">CrowdStrike</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) today announced it has agreed to acquire Adaptive Shield, a leader in SaaS Security. With this acquisition, CrowdStrike will be the only cybersecurity vendor to provide unified, end-to-end protection against identity-based attacks across the entire modern cloud ecosystem – from on-premises Active Directory to cloud-based identity providers and SaaS applications – delivered from a single, unified platform. Announced at <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.crowdstrike.com%2Fevents%2Ffal-con%2Feurope%2F&amp;esheet=54147816&amp;newsitemid=20241106324741&amp;lan=en-US&amp;anchor=Fal.Con+Europe&amp;index=2&amp;md5=e7219e94d2ead6847062eedd1ce8f3cf">Fal.Con Europe</a>, CrowdStrike's inaugural premier user conference in the region, this acquisition will position CrowdStrike as the leading provider of comprehensive protection across complex hybrid environments.

CRWD

CrowdStrike Expands Cybersecurity Reach with Acquisition of Adaptive Shield

Former President Donald Trump declared victory in the 2024 presidential election after winning <a href="https://www.benzinga.com/news/24/11/41762845/trump-wins-kentucky-indiana-harris-scores-vermont-as-polls-begin-to-close-across-us">the key battleground states</a>. Trump, who was addressing his supporters in New York, also praised his running mate, JD Vance, and acknowledged the role of tech mogul Elon Musk in his campaign.
What Happened: Trump, in his victory speech, lauded his supporters for overcoming seemingly insurmountable challenges on Tuesday night. He expressed his determination to &#8220;fix everything about our country&#8221; and described his win as &#8220;the greatest political movement of all time.&#8221;
According to <a href="https://apnews.com/live/trump-harris-election-updates-11-5-2024">the</a> latest numbers from The Associated Press, Trump has 267 out of the 270 electoral votes needed for victory. The Republican party is currently leading in key states like Michigan and Wisconsin, which are yet to be called.
Trump secured a victory in Pennsylvania, earning 19 electoral votes after capturing over 51% of the vote in this pivotal swing state.
&#8220;I want to thank the American people for the extraordinary honor of being elected your 47th president and your 45th president,&#8221; Trump said.
See Also: <a href="https://www.benzinga.com/news/24/11/41736493/microsoft-co-founder-bill-gates-says-everyone-in-future-will-have-a-utilitarian-ai-agent-that-will-h?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Microsoft Co-Founder Bill Gates Says Everyone In Future Will Have A &#8216;Utilitarian AI Agent&#8217; That Will Help</a>
Trump also addressed the criticism faced by Vance, his vice-presidential pick, for comments that were perceived as hostile to women. Despite the initial backlash, Trump praised Vance&#8217;s intellect and called him a &#8220;feisty guy.&#8221;
Trump also celebrated his party&#8217;s victory in the U.S. Senate, which he believes will aid in confirming his Cabinet members and nominating judges.
Trump asserted that he had won both the popular vote and an Electoral College landslide with over 300 votes, although the final counts are still pending in several states.
Trump also acknowledged the support of his family and campaign team, and when asked about Musk, he hailed the tech mogul as a &#8220;new star&#8221; and an &#8220;amazing guy.&#8221;
Why It Matters: On election night, <a href="https://www.benzinga.com/markets/equities/24/11/41763478/trump-media-reddit-devon-energy-super-micro-computer-and-tesla-buzzing-among-investors-on-electi">Trump&#8217;s media company</a>, Trump Media &amp; Technology Group Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>), experienced a substantial surge in its shares, driven by the anticipation of the election results and the company&#8217;s third-quarter financial results.
Trump&#8217;s victory in the 2024 presidential race, including his win in the key swing state of North Carolina, has been a significant factor in the stock market&#8217;s movements.
The <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41765518/5-things-moving-as-trump-trade-fever-sweeps-wall-street-amid-election-night-drama">stock futures also experienced a rise</a> on election night. Futures associated with the Dow Jones Industrial Average increased by 739 points, or 1.74%, as of 2 a.m. ET. Futures linked to the S&amp;P 500 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) were up by 1.42%.
Treasury yields also<a href="https://www.benzinga.com/news/24/11/41765345/treasury-yields-pop-on-trump-victory-chances-10-year-benchmark-reaches-4-month-high" target="_blank" rel="noreferrer noopener">&nbsp;saw an increase in overnight trading&nbsp;</a>as investors evaluated the early results of the tight presidential race. The 10-year Treasury yield jumped 14 basis points to 4.431%, hitting its highest level since July 2.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/11/41703265/haley-tells-pennsylvania-voters-to-put-emotion-aside-and-rally-behind-trump?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Haley Tells Pennsylvania Voters To Put Emotion Aside And Rally Behind Trump</a></li>
</ul>
Photo courtesy: Shutterstock

General

Trump Gives Victory Speech In Florida As Winning Pennsylvania Puts Him At Brink Of Victory, Vows To 'Fix Everything About Our Country'

Republicans have taken control of the U.S. Senate, following victories in West Virginia and Ohio on Tuesday. This shift ensures that Donald Trump&#8217;s party will control at least one chamber of Congress in the coming year.
Jim Justice (R &#8211; W.Va) was projected to win an open Senate seat in West Virginia, succeeding Joe Manchin (I-W.Va.), a Democrat-turned-independent. In Ohio, Bernie Moreno (R-Ohio) was projected to defeat incumbent Democrat Sherrod Brown (D- Ohio). These wins secure a 51-49 Republican majority in the Senate, with potential for further gains as additional results are tallied, Reuters reported on Wednesday.
See Also: <a href="https://www.benzinga.com/news/24/11/41710411/market-analyst-who-predicted-trumps-2016-win-and-bidens-2020-victory-now-sees-former-president-retak?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Market Analyst Who Predicted Trump&#8217;s 2016 Win And Biden&#8217;s 2020 Victory, Now Sees Former President Retaking The White House With &#8216;Large Majority Of Swing States&#8217;</a>
Republicans also made early gains in the House of Representatives, aiming to expand their 220-212 majority. They captured a Democratic-held district in Pennsylvania, President Joe Biden&#8217;s hometown of Scranton, and gained seats in North Carolina after redistricting. However, Democrats flipped a Republican seat in New York and another in Alabama, following a Supreme Court order to create a Black majority district.
In Delaware, Sarah McBride (D- Del.) made history as the first openly transgender member of Congress. Meanwhile, tight races in New York and California could determine the final House control, with results possibly delayed due to lengthy ballot counts in California.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41733346/obamas-former-campaign-manager-alarmed-by-early-voting-numbers-as-harris-trump-fight-close-battle-re?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Obama&#8217;s Former Campaign Manager Alarmed By Early Voting Numbers As Harris-Trump Fight Close Battle: &#8216;Republicans Didn&#8217;t Do What They Did Last Time&#8217;</a></li>
</ul>
Image via Pexels
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.

Trump-Led Republicans Get Hold Of US Senate With West Virginia, Ohio Wins

The CNN Money Fear and Greed index showed an improvement in the overall market sentiment, but the index remained in the &#8220;Fear&#8221; zone on Tuesday.
U.S. stocks settled higher on Monday, with the Dow Jones index gaining more than 400 points as investors awaited the results of the U.S. presidential election. The Federal Reserve is also scheduled to announce its November rate decision on Thursday.
On the economic data front, the trade deficit in the U.S. increased to $84.4 billion in September, recording the highest level since April 2022, and above market estimates of a $84.1 billion gap, versus a revised $70.8 billion gap in August. The ISM services PMI rose to 56 in October, recording the highest reading since Aug. 2022.
Yum! Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUM#NYSE">YUM</a>) posted downbeat results for its third quarter. Shares of Vimeo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMEO#NASDAQ">VMEO</a>) jumped around 45% on Tuesday after the company reported better-than-expected third-quarter financial results and issued fourth-quarter sales guidance above estimates.
All sectors on the S&amp;P 500 closed on a positive note, with consumer discretionary, industrials, and utilities stocks recording the biggest gains on Tuesday.
The Dow Jones closed higher by around 427 points to 42,221.88 on Tuesday. The S&amp;P 500 gained 1.23% to 5,782.76, while the Nasdaq Composite jumped 1.43% to close at 18,439.17 during Tuesday's session.
Investors are awaiting earnings results from CVS Health Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>), Johnson Controls International plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JCI#NYSE">JCI</a>), and Qualcomm Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 43.5, the index remained in the &#8220;Fear&#8221; zone on Tuesday, versus a prior reading of 41.2.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/41744659/jim-cramer-says-he-cant-recommend-this-major-automaker-ceva-is-way-too-high">Jim Cramer Says He Can&#8217;t Recommend This Major Automaker, Ceva Is &#8216;Way Too High&#8217;</a></li>
</ul>
Photo courtesy: Shutterstock

Earnings

Pre-Market Outlook

Markets

QCOM

VMEO

Dow, Nasdaq Jump Over 1% Ahead Of Election Results: Investor Sentiment Improves, But Greed Index Remains In 'Fear' Zone

Peoples Financial Servs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFIS#NASDAQ">PFIS</a>) reported quarterly earnings of $1.64 per share which beat the analyst consensus estimate of $1.07 by 53.27 percent. The company reported quarterly sales of $44.966 million which beat the analyst consensus estimate of $37.000 million by 21.53 percent. This is a 80.09 percent increase over sales of $24.969 million the same period last year.

Earnings Beats

PFIS

Peoples Financial Servs Q3 2024 Adj. EPS $1.64 Beats $1.07 Estimate, Sales $44.966M Beat $37.000M Estimate

TSLA

Benzinga Election Update: At the Watch Party, Donald Trump Calls Elon Musk By Name, Says, "A New Star Is Born"

Elon Musk reported that X, formerly known as Twitter, experienced a significant surge in activity during the U.S. elections. 
What Happened: In a post on Wednesday, Musk shared a chart illustrating hourly mobile usage in the U.S., which showed a dramatic increase starting at 5 a.m. and peaking at 6 billion seconds by 11 p.m. ET.
This increase in usage aligns with the heightened interest in the Presidential election. As of the latest updates, Donald Trump was leading with 248 electoral votes, while Kamala Harris was trailing with 214 votes. The target for either candidate is to achieve 270 electoral votes to secure the presidency.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Record usage of this platform!! <a href="https://t.co/SfWyi9kBWd">pic.twitter.com/SfWyi9kBWd</a>
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1854042843142373793?ref_src=twsrc%5Etfw">November 6, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/markets/asia/24/11/41722178/if-trump-and-republicans-sweep-dollar-may-climb-7-but-harris-win-could-bring-5-drop-says-jpmorgan?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">If Trump And Republicans Sweep, Dollar May Climb 7% — But Harris Win Could Bring 5% Drop, Says JPMorgan</a>
Why It Matters: The spike in activity on X during the election highlights the platform&#8217;s role in political discourse. Recently, Musk discussed the pressure he faced regarding the potential shutdown of X, comparing it to the challenges faced by Trump. During an appearance on Tucker Carlson's online show, Musk downplayed<a href="https://www.benzinga.com/news/24/11/41765113/elon-musk-tells-tucker-carlson-that-the-pressure-he-faced-for-shutting-down-x-pales-in-comparison-wi"> his own experiences</a>, emphasizing the greater difficulties encountered by Trump. This conversation took place on Election Day from Trump's Mar-a-Lago estate. 
Additionally, Musk has expressed intentions to expand his <a href="https://www.benzinga.com/news/24/11/41763360/elon-musk-is-already-eyeing-2026-midterms-plans-to-expand-pro-trump-pac-beyond-current-election-ther">pro-Trump super PAC</a> beyond the current election, with a focus on the 2026 midterms and local races. He suggested that a Trump victory would reflect a public desire for change, indicating a potential shift in the political landscape. Musk&#8217;s remarks came during a live session on X, where he noted, "I think there&#8217;s a sea change in the country." 
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41733899/trump-woos-muslim-voters-says-hes-building-the-biggest-and-broadest-peace-coalition-kamala-and-her-w?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Trump Woos Muslim Voters, Says He&#8217;s &#8216;Building The Biggest And Broadest&#8217; Peace Coalition: &#8216;Kamala And Her&nbsp;Warmonger Cabinet Will Invade The Middle East&#8217;</a></li>
</ul>
Image via Shutterstock

Social Media

Tech

Elon Musk Says X Saw 'Record Usage' On Election Day As Trump Closes In On White House Win

With U.S. stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects CVS Health Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) to report quarterly earnings at $1.53 per share on revenue of $92.75 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. CVS Health shares rose 0.7% to $55.70 in after-hours trading.</li>
<li>Globus Medical, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMED#NYSE">GMED</a>) reported better-than-expected third-quarter financial results and issued FY24 guidance above estimates. The company reported quarterly earnings of 83 cents per share which beat the analyst consensus estimate of 65 cents per share. The company reported quarterly sales of $625.71 million which beat the analyst consensus estimate of $603.93 million. Globus Medical shares surged 10.3% to $83.35 in the after-hours trading session.</li>
<li>Analysts are expecting Johnson Controls International plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JCI#NYSE">JCI</a>) to post quarterly earnings at $1.2 per share on revenue of $7.17 billion. The company will release earnings before the markets open. Johnson Controls International shares rose 2.3% to $76.55 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) lowered its financial outlook. The company expects to report first-quarter revenue of $5.9 billion to $6 billion, down from its previous guidance range of $6 billion to $7 billion. The company anticipates adjusted earnings of 75 cents to 76 cents per share, versus its previous guidance of 67 cents to 83 cents per share. Super Micro Computer shares dipped 16% to $23.28 in the after-hours trading session.</li>
<li>Analysts expect Qualcomm Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) to report quarterly earnings at $2.56 per share on revenue of $9.9 billion after the closing bell. QUALCOMM shares gained 0.2% to $166.19 in after-hours trading.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/41744659/jim-cramer-says-he-cant-recommend-this-major-automaker-ceva-is-way-too-high">Jim Cramer Says He Can&#8217;t Recommend This Major Automaker, Ceva Is &#8216;Way Too High&#8217;</a></li>
</ul>
Photo courtesy: Shutterstock

Equities

GMED

SMCI

CVS Health, Johnson Controls And 3 Stocks To Watch Heading Into Wednesday

Benzinga Election Update: AP Projects Trump With 267 Electoral Votes, Harris With 214 Electoral Votes, AP Calls Trump Win In Pennsylvania

<a href="https://www.youtube.com/watch?v=7Vn6dYEX2_s  " title="https://www.youtube.com/watch?v=7Vn6dYEX2_s  ">https://www.youtube.com/watch?v=7Vn6dYEX2_s&nbsp;&nbsp;</a>

Macro Economic Events

Econ #s

Economics

47th President Donald. J. Trump Speaks At Campaign Watch Party In Florida

EV startup Canoo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOEV#NASDAQ">GOEV</a>) appointed Kunal Bhalla as its Chief Financial Officer on Oct. 31, following the resignation of Greg Ethridge.
What Happened: Bhalla has been with Canoo since late 2020 and served in multiple roles. Before Canoo, he was an investment banker with Rothschild and Co. as a Director of M&amp;A focused on the Mobility Technology sector.
Ethridge&#8217;s resignation was not the sole one recently at Canoo. Hector Ruiz, General Counsel and Corporate Secretary of Canoo, also resigned from the startup on Oct. 31. The company subsequently chose Sean Yan as&nbsp;General Counsel.
Canoo also said that it will temporarily reduce its workforce in Oklahoma City by furloughing 23% of its factory workers for a period of twelve weeks.&nbsp;
Why It Matters: Canoo in September <a href="https://www.benzinga.com/news/24/08/40570834/ev-startup-canoo-follows-teslas-footsteps-to-move-headquarters-from-california-to-texas">named Justin, Texas</a> as its new company headquarters. The company then said that about 137 engineering positions will relocate from California to Texas and Oklahoma beginning in the fourth quarter of 2024 as part of the headquarters relocation.
Canoo&#8217;s finances have recently been under duress. For the <a href="https://www.benzinga.com/news/earnings/24/08/40380998/canoo-reports-q2-results-reduced-expenses-lower-cash-outflow">three months ending June</a>, Canoo reported a revenue of $605,000 and adjusted net loss per share of $0.61. The company had cash, cash equivalents, and restricted cash of just $19.1 million as of Jun. 30.
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41738613/elon-musk-rejects-rumors-of-a-tesla-phone-but-says-the-ev-giant-will-have-to-make-one-if-this-happen" target="_blank" rel="noreferrer noopener">Elon Musk Rejects Rumors Of A Tesla Phone, But Says The EV Giant Will Have To Make One If This Happens</a></li>
</ul>
Photo courtesy: Canoo

GOEV

EV Startup Canoo To Furlough 23% Factory Workers In Oklahoma City, CFO Departs

AVPT

Reported Earlier, AvePoint Unveils AI Lab In Singapore To Advance AI And Machine Learning In Data Management

Reported Earlier, HUTCHMED To Present Long-Term Data On Sovleplenib For Chronic ITP At 2024 ASH And ESMO Asia Congress

In connection with the private placement, the Company is planning to issue an aggregate of 2,137,850 units. Each unit will be sold at an effective unit price of $4.28 per unit and will consist of one share of common stock (or one pre-funded warrant in lieu thereof), two (2) Series A warrants, each exercisable for one share of common stock at an initial exercise price of $4.03 per share and one Series B warrant at an exercise price of $0.0001 to purchase such number of shares of common stock as will be determined on the Reset Date (as defined in the Series B warrant).&nbsp;
The closing of the private placement is expected to occur on or about November 6, 2024, subject to the satisfaction of certain customary closing conditions.

ZCAR

Zoomcar Prices $9.15M Private Placement To Advance Debt Repayment And Corporate Growth

As the U.S. presidential election hits a climax with former President Donald Trump taking the lead over Kamala Harris, these five key movements are happening across Wall Street.
Trump Media &amp; Technology Group Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>): The shares of Trump&#8217;s media company have experienced a significant surge fueled by both the anticipation of the election results and the company&#8217;s third-quarter financial results. Data from Nasdaq revealed that the after-hours trading volume for the stock was at 21.9 million, with the stock trading 10.43% higher at $37.48 on Tuesday during after-market hours.
Stock Futures: The stock futures also experienced a rise on election night. Futures associated with the Dow Jones Industrial Average increased by 739 points, or 1.74%, as of 2 a.m. ET. Futures linked to the S&amp;P 500 were up by 1.42%.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>): The anticipation of Trump&#8217;s return to White also boosted Bitcoin to surpass the 75,000 mark and reached 75,249.06 at the time of writing on Wednesday early morning.
See Also: <a href="https://www.benzinga.com/markets/equities/24/11/41703265/haley-tells-pennsylvania-voters-to-put-emotion-aside-and-rally-behind-trump?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Haley Tells Pennsylvania Voters To Put Emotion Aside And Rally Behind Trump</a>
Treasury Yields: Treasury yields also<a href="https://www.benzinga.com/news/24/11/41765345/treasury-yields-pop-on-trump-victory-chances-10-year-benchmark-reaches-4-month-high"> saw an increase in overnight trading </a>as investors evaluated the early results from the tight presidential race. The 10-year Treasury yield jumped 14 basis points to 4.431%, hitting its highest level since July 2. The yield on the 2-year Treasury was up by 8 basis points to 4.285%, reaching its highest level since July 31.
Dollar: The Bloomberg Dollar Spot Index rose sharply by 1.4%, marking its highest point in over three months. The U.S. dollar strengthened across the board against all G10 currencies, with notable increases of over 1% against both the euro and the yen.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41710411/market-analyst-who-predicted-trumps-2016-win-and-bidens-2020-victory-now-sees-former-president-retak?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Market Analyst Who Predicted Trump&#8217;s 2016 Win And Biden&#8217;s 2020 Victory, Now Sees Former President Retakin</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Image via Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

5 Things Moving As Trump Trade Fever Sweeps Wall Street Amid Election Night Drama

AudioCodes (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUDC#NASDAQ">AUDC</a>) reported quarterly earnings of $0.16 per share which missed the analyst consensus estimate of $0.23 by 30.43 percent. This is a 36 percent decrease over earnings of $0.25 per share from the same period last year. The company reported quarterly sales of $60.243 million which missed the analyst consensus estimate of $61.192 million by 1.55 percent. This is a 2.19 percent decrease over sales of $61.591 million the same period last year.

Earnings Misses

AUDC

AudioCodes Q3 2024 Adj. EPS $0.16 Misses $0.23 Estimate, Sales $60.243M Miss $61.192M Estimate

Sales growth is now expected to be 23% to 27% at CER.&nbsp;
Given the current exchange rates versus the Danish krone, sales growth reported in DKK is still expected to be 1 percentage point lower than at CER. The guidance reflects expectations for sales growth in both North America Operations and International Operations, mainly driven by volume growth of GLP-1-based treatments for Obesity and Diabetes care. Continued pricing pressure within Diabetes and Obesity care is included in the guidance.&nbsp;
Following higher-than-expected volume growth in recent years, including GLP-1-based products such as Ozempic&#xAE; and Wegovy&#xAE; , combined with the expectation of continued volume growth and capacity limitations at some manufacturing sites, the outlook also reflects expected continued periodic supply constraints and related drug shortage notifications across a number of products and geographies. Novo Nordisk is investing in internal and external capacity to increase supply both short and long-term.
Operating profit growth is now expected to be 21% to 27% at CER. Given the current exchange rates versus the Danish krone, growth reported in DKK is now expected to be 2 percentage points lower than at CER.
The expectation for operating profit growth primarily reflects the sales growth outlook and continued investments in future and current growth drivers within Research, Development and Commercial. Within R&amp;D, investments are related to the continued expansion and progression of the early and late-stage pipeline. Commercial investments are mainly related to Obesity care market development activities as well as investments related to GLP-1 diabetes care.&nbsp;
Novo Nordisk now expects financial items (net) to amount to a loss of around DKK 0.1 billion. The effective tax rate for 2024 is now expected to be in the range of 20-21%.&nbsp;
Capital expenditure is still expected to be around DKK 45 billion in 2024, reflecting expansion of the global supply chain. The investments will create additional capacity across the supply chain, including manufacturing of active pharmaceutical ingredients (API), additional aseptic production and finished production processes as well as packaging capacity. In the coming years, the capital expenditure to sales ratio is still expected to be low double-digit.&nbsp;
Depreciation, amortisation and impairment losses are still expected to be around DKK 17 billion, including the impairment of ocedurenone.

Guidance

Novo Nordisk 2024 Outlook, Updated: Now Expects Sales Growth Of 23%-27% (Prior 22%-28%) And Operating Profit Growth Of 21%-27% (Prior 20%-28%)

Germany Factory Orders (MoM) For September 4.2% Vs. 1.6% Est.; -5.8% Prior

Sera Prognostics GAAP EPS of -$0.25 beats by $0.02

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Sera Prognostics (NASDAQ:<a href="https://investorplace.com/stock-quotes/sera-stock-quote/">SERA</a>) just reported results for the first quarter of 2024.<ul><li>Sera Prognostics reported earnings per share of -25 cents. This was above the analyst estimate for EPS of -27 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/sera-stock-earnings-sera-prognostics-for-q1-of-2024/">SERA Stock Earnings: Sera Prognostics Beats EPS for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

SERA Stock Earnings: Sera Prognostics Beats EPS for Q1 2024

Sera Prognostics, Inc. (SERA) Q1 2024 Earnings Call Transcript

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Buying stocks that can make you <a href="https://investorplace.com/2024/04/3-stocks-under-10-that-could-make-you-a-millionaire-by-2030/">millions</a> is any investor&rsquo;s dream. That is why some investors consider micro-cap or small-cap stocks trading under $10. Doing so lets them buy into the business and potentially make a killing if their thesis is right.&nbsp;



But it is also a double-edged sword. When you get it wrong, losses can magnify. That is why it is important to screen for companies now, not only on price but also for significant improvements in the business, like revenue and earnings growth, to help qualify the ones that offer better growth potential in the long run.



So, in this article, I looked at stocks under $10 that have the potential to skyrocket into high double- or even triple-digits. To get the list, I used the following criteria.



<ul><li>Stock trades between $5 to $10</li>



<li>Has at least a Buy rating from analysts</li>



<li>Latest full-year earnings growth or improvement of at least 10%</li>



<li>Consistent positive revenue growth in the last three years</li>
</ul>This set of criteria gave me some of the best stocks under $10.



Here are the results, sorted by earnings growth (highest to lowest).



<h2>Materialise NV (MTLS)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/software1600d-300x169.jpg" alt="A man examines a digital screen with different icons for software."><div>Source: Shutterstock</div></div>3D printing demands are rising, and companies like Materialise NV (NASDAQ:<a href="https://investorplace.com/stock-quotes/mtls-stock-quote/">MTLS</a>) are capitalizing on this growth.&nbsp;



Materalise provides software and 3D printing services for various applications. The company aims to transform businesses through repeatability, reliability and quality. It recently launched <a href="https://www.materialise.com/en/news/press-releases/mimics-enlight-cmf-3d-surgical-planning">Mimics Enlight CMF,</a> a pre-operative planning solution, to enhance the in-house planning experience of its healthcare customers, who aim to use 3D software for surgical application planning.&nbsp;



In addition, the company has also launched a personalized <a href="https://www.materialise.com/en/news/press-releases/fully-personalized-tmj-total-arthroplasty-system">TMJ implant,</a> which treats patients requiring total temporomandibular joint (TMJ) arthroplasty at a 100% success rate after one year of treatment. Patients with the implant report an improved quality of life, among other good news.&nbsp;



Materialise reported an impressive <a href="https://investors.materialise.com/news-releases/news-release-details/materialise-reports-fourth-quarter-and-full-year-2023-results">10.4% YOY increase in revenue for 2023,</a> with its medical segment blasting through the 100 million euro revenue benchmark. EBITDA increased by 65%, and the bottom line went from a 0.04 euro cent loss to a 0.11 euro profit.&nbsp;



The company&rsquo;s <a href="https://finance.yahoo.com/quote/MTLS/financials/">revenue is growing steadily,</a> and analysts are happy to give it a <a href="https://www.nasdaq.com/market-activity/stocks/mtls/analyst-research">Strong Buy rating</a> with 134% upside potential based on the high target price. With its growth and prospects in the green, MTLS might be one of the best stocks trading under $10.&nbsp;



<h2>Ardelyx (ARDX)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/04/ardx1600-300x169.png" alt="Ardelyx (ARDX) s a biopharmaceutical firm focused on the discovery, development, and commercialization of innovative, non-systemic, small molecule therapies"><div>Source: MacroEcon / Shutterstock.com</div></div>Ardelyx (NASDAQ:<a href="https://investorplace.com/stock-quotes/ardx-stock-quote/">ARDX</a>) is a biotech company specializing in developing and commercializing advanced medicine, specifically diseases with unmet needs.&nbsp;



The company currently has two main commercial products in the market: XPHOZAH, for CKD patients in dialysis, and IBSRELA, for patients with constipation due to irritable bowel syndrome.



Ardelyx currently has two pipeline programs: RDX013, which aims to treat hyperkalemia, and RDX020, which is for metabolic acidosis treatment. The company aggressively promotes its commercial products and presents new data supporting their efficacy.



As for financials, Ardelyx <a href="https://ir.ardelyx.com/node/12856/pdf#:~:text=Revenues%3A%20Total%20revenues%20for%20the,to%20%2415.6%20million%20in%202022.">ended 2023 with a massive revenue boost,</a> mostly driven by IBSRELA, which hit $80 million in sales, up from last year&rsquo;s $15.6 million. Including product supplies and licensing, total revenue reached $124.5 million. Revenue has also increased <a href="https://finance.yahoo.com/quote/MTLS/financials/">for the last three years,</a> lending more weight to management&rsquo;s optimism.&nbsp;



The company is still operating at a loss, but things are expected to improve as it launches more products. Meanwhile, Ardelyx reported a net loss of 30 cents per share in 2023, a sizable improvement from last year&rsquo;s 42 cents a share loss.&nbsp;



With a current price of around $6 to $7 and a <a href="https://www.nasdaq.com/market-activity/stocks/ardx/analyst-research">Strong Buy rating</a> with an impressive $15 high target price, investors looking for great <a href="https://investorplace.com/stock-types/growth-stocks/">growth stocks</a> under $10 might strike gold with ARDX.



<h2>Sera Prognostics (SERA)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/04/pte_biotech_1600-300x169.png" alt="Medical technology network team meeting concept. Doctor hand working smart phone modern digital tablet laptop computer graphics chart interface, sun flare effect photo, PTE"><div>Source: everything possible / Shutterstock.com</div></div>Known for its proprietary proteomics and bioinformatics platform, Sera Prognostics (NASDAQ:<a href="https://investorplace.com/stock-quotes/sera-stock-quote/">SERA</a>) is a health diagnostic company for women. Using its platform, the company can discover and validate key biomarkers of its patients to use accurate predictors of the dynamic changes that occur during pregnancy. The company&rsquo;s commercial PreTRM test is a non-invasive blood biomarker test that helps health professionals predict the potential of a preterm birth.&nbsp;



Last year, Sera reported its Prematurity Risk Assessment Combined with Clinical Interventions for Improved Neonatal OutcoMEs, or PRIME study, <a href="https://finance.yahoo.com/news/sera-prognostics-announces-primary-endpoint-133000734.html">moved</a> from enrollment to data analysis and reporting. The Data Safety Monitoring Board (DSMB) recommended this move after the study met primary endpoints, which is good news for the company and its investors.&nbsp;



In 2023, Sera Prognostics&rsquo; revenue increased from <a href="https://seraprognostics.com/about/newsroom/sera-prognostics-reports-fourth-quarter-2023-financial-results/">$268,000 to $306,000,</a> continuing a multi-year streak of sales improvement. Meanwhile, the bottom line improved from a $1.43 loss in 2022 to a $1.16 loss in 2023.&nbsp;



According to its recent filings, the company expects increased product demand. &ldquo;Our new ambient whole blood collection method,&rdquo; stated <a href="https://seraprognostics.com/about/newsroom/sera-prognostics-reports-first-quarter-2024-financial-results/">CEO and President Zhenya Lindgardt,</a> &ldquo;allows us to access more patients and, as revenue ramps, we expect should significantly improve gross margin and enable Sera to process more tests efficiently to meet future demand.&rdquo;



No wonder analysts continue to rate the stock as a Strong Buy. Investors looking for <a href="https://investorplace.com/industries/healthcare/">healthcare stocks</a> trading under $10 should look at SERA.



On the date of publication, Rick Orford did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines.</a>
<div>Rick Orford is a Wall Street Journal best-selling author, investor, influencer, and mentor. His work has appeared in the most authoritative publications, including Good Morning America, Washington Post, Yahoo Finance, MSN, Business Insider, NBC, FOX, CBS, and ABC News.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/06/3-stocks-under-10-with-the-potential-to-make-you-a-millionaire/">3 Stocks Under $10 With the Potential to Make You a Millionaire</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

3 Stocks Under $10 With the Potential to Make You a Millionaire

Sera Prognostics joins Russell 2000, Russell 3000 indexes

Sera Prognostics GAAP EPS of -$0.25 beats by $0.02, revenue of $0.02M misses by $0.08M

Sera Prognostics files $100M mixed securities shelf

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Sera Prognostics (NASDAQ:<a href="https://investorplace.com/stock-quotes/sera-stock-quote/">SERA</a>) just reported results for the second quarter of 2024.<ul><li>Sera Prognostics reported earnings per share of -25 cents. This was above the analyst estimate for EPS of -26 cents.</li><li>The company reported revenue of $24,000.</li><li>This was 70% worse than the analyst estimate for revenue of $80,000.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/sera-stock-earnings-sera-prognostics-for-q2-of-2024/">SERA Stock Earnings: Sera Prognostics Beats EPS, Misses Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

SERA Stock Earnings: Sera Prognostics Beats EPS, Misses Revenue for Q2 2024

TD Cowen analyst Daniel Brennan maintained a Buy rating on Sera Prognostics (SERA – Research Report) today. The company's shares closed yesterday a...

TD Cowen Sticks to Their Buy Rating for Sera Prognostics (SERA)

Sera Prognostics, Inc. (SERA) Q2 2024 Earnings Call Transcript

ARDX

MTLS

Press Releases

Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2024 Financial Results on May 8, 2024

SERA PROGNOSTICS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

SERA PROGNOSTICS EXPECTED TO BE ADDED TO RUSSELL 2000 AND 3000 INDEXES

SERA PROGNOSTICS ADDED TO RUSSELL 2000 AND 3000 INDEXES FOLLOWING CONCLUSION OF 2024 INDEXES ANNUAL RECONSTITUTION

Sera Prognostics PreTRM® Test Prevention Strategy Demonstrates 18% Reduction in Severe Neonatal Morbidity and Mortality in Newly Published AVERT Trial

Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2024 Financial Results on August 7, 2024

SERA PROGNOSTICS REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS

Sera Prognostics to Participate in Panel Discussion at UBS Genomic Medicine Summit on August 14, 2024

Sera Prognostics to Present at H.C. Wainwright 26th Annual Global Investment Conference

Sera Prognostics Announces Conference Call and Webcast of Third Quarter Fiscal Year 2024 Financial Results on November 6, 2024

Abeona Therapeutics

Acrivon Therapeutics, Inc. - Common Stock

Acrivon Therapeutics

Amarin Corporation plc - American Depositary Shares, each representing one Ordinary Share

Amarin Corp

Anika Therapeutics

Artiva Biotherapeutics, Inc. - Common Stock

Artiva Biotherapeutics

aTyr Pharma

Climb Bio

Compass Therapeutics, Inc. - Common Stock

Compass Therapeutics

Editas Medicine

Enanta Pharmaceuticals, Inc. - Common Stock

Enanta Pharma

Genfit

Heron Therapeutics

Immutep Limited - American Depositary Shares

Immutep

Inozyme Pharma

Lexeo Therapeutics

Ocugen

Precigen

Poseida Therapeutics, Inc. - Common Stock

Poseida Therapeutics

AVITA Medical

Rigel Pharmaceuticals, Inc. - Common Stock

Rigel Pharmaceuticals

TScan Therapeutics

Taysha Gene Therapies, Inc. - Common Stock

Taysha Gene Therapies

Vanda Pharmaceuticals Inc. - Common Stock

Vanda Pharma

Zentalis Pharmaceuticals, Inc. - common stock

Zentalis Pharma

Zura Bio Limited - Class A Ordinary shares

Zura Bio

Citigroup

Oppenheimer

Berenberg

매주, ‘벤징가의 스톡 위스퍼 지수(Benzinga's Stock Whisper Index)'는 독점 데이터(proprietary data)와 패턴 인식의 조합을 사용하여 <a href="https://www.benzinga.com/topic/stock-whisper-index" target="_blank" rel="noreferrer noopener">표면 바로 아래에서 주목</a>을 받을 만한 주식 5종목을 소개한다.
투자자들은 가치가 저평가된, 관심이 적은, 새로운 주식들을 항상 찾고 있다. 소매 거래자들이 사용할 수 있는 방법은 무수히 많기 때문에 새로운 기회를 발견하고 특정 주식이 관심을 가져야 하는 이유를 이해하기 위해 풍부한 정보를 조사하는 것이 어려운 경우가 많다.
다음은 11월 1일 주간 벤징 &#8216;주식 위스퍼&#8217; 지수의 개요:
애질런트 테크놀로지스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>):
투자자들의 관심이 증가하고 있으며, 이는 여러 잠재적 촉매제가 앞두고 있기 때문이다. 생명과학 및 진단 회사인 애질런트는 11월 25일에 4분기 재무 결과를 발표하고, 12월 17일에 애널리스트 데이를 개최할 예정이다. <a href="https://www.benzinga.com/quote/A/analyst-ratings" target="_blank" rel="noopener" data-google-interstitial="false">최근</a> 바클레이즈가 이 주식에 대해 비중축소(Underweight) 등급을 유지하면서 목표 주가를 135달러에서 145달러로 상향 조정한 후 주가가 상승했다. 에버코어 ISI는 인라인 등급을 유지하면서도 목표 주가를 135달러에서 145달러로 상향 조정했다. 주가는 금요일 5.03% 상승한 136.87달러에 마감했다. 지난 5거래일 동안 4.08% 상승했으며, 2024년 현재 연초 대비 1.35% 하락한 상태다.
<img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01143840/Screenshot-227.png?optimize=medium&amp;dpr=1.25&amp;auto=webp&amp;width=2048" />
트레이드 데스크(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>):
3분기 재무 결과 발표를 앞두고 투자자들의 관심이 증가했다. 11월 7일에 3분기 실적이 발표될 예정이며, 애널리스트들은 주당 39센트의 이익과 6억 1,980만 달러의 매출을 예상하고 있다. 이는 작년 3분기 주당 33센트의 이익과 4억 9,330만 달러의 매출과 비교된다. 트레이드 데스크는 최근 8개 분기 중 7개 분기에서 주당 이익 추정치를 초과했으며, 매출 추정치는 10개 분기 이상 초과했다.
웨드부시(Wedbush)의 애널리스트인 댄 아이브스는 트레이드 데스크의 성장 잠재력을 <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41144914/meta-trade-desk-amazon-digital-ad-titans-set-for-strong-2025-growth-tech-analyst-sa" target="_blank" rel="noopener" data-google-interstitial="false">강조</a>했다.
아이브스는 &#8220;우리 조사에 따르면 2분기 대비 3분기에 TTD의 성장이 가속화되는 것으로 나타났다&#8221;고 말했다.
트레이드 데스크의 <a href="https://www.benzinga.com/news/earnings/24/08/40267737/the-trade-desk-stock-climbs-after-better-than-expected-q2-results" target="_blank" rel="noopener" data-google-interstitial="false">2분기 실적</a>에 따르면 고객 유지율은 95%가 넘으며 10년 연속 이어졌다. 잠재적인 강력한 성장과 인공지능(AI) 이니셔티브가 통합되면서 주식은 3분기 실적에 대해 약간의 화제를 불러일으킬 수 있다.
주가는 금요일 0.85% 하락한 119.19달러에 마감되었다. 지난 5일 동안 0.82% 하락했으나, 2024년 연초 대비 68.85% 상승했다.
<img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01143856/Screenshot-228.png?optimize=medium&amp;dpr=1.25&amp;auto=webp&amp;width=2048" />
Schwab US Dividend Equity ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHD#NYSE">SCHD</a>):
이 ETF가 처음으로 리스트에 등장했다. 스톡 위스퍼 지수는 일반적으로 주식만 강조하고 ETF는 제외하지만, 매주 SPY, QQQ와 같은 잘 알려진 ETF들이 변동성을 기반으로 관심이 상승하는 경우가 있다. 슈왑(Schwab)은 Dow Jones U.S. Dividend 100 Index를 추적한다. 이는 배당금을 지급하고 배당금 지급 실적이 우수한 미국 대기업들에 대한 노출을 제공한다. 이 ETF의 주요 보유 종목에는 브리스톨 마이어스 스퀴브(Bristol Myers Squibb), 블랙록, 시스코 시스템즈, 홈 디포 및 쉐브론이 포함된다.
글로벌 긴장 고조, 거시경제 불확실성, 2024년 대통령 선거로 인해 일부 투자자들이 불안해하는 상황에서, 이 ETF가 배당 소득과 블루칩 회사들에 대한 투자로 인해 관심이 증가하고 있을 수 있다.
이 ETF는 금요일 0.46% 하락한 28.10달러에 마감되었다. 올해 들어 9.94% 올랐다.
<img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01143913/Screenshot-229.png?optimize=medium&amp;dpr=1.25&amp;auto=webp&amp;width=2048" />
리인슈런스 그룹(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>):
생명 및 건강 재보험 회사로, 분기 재무 <a href="https://investor.rgare.com/news-releases/news-release-details/reinsurance-group-america-reports-record-third-quarter-results" target="_blank" rel="noopener">결과</a>로 인해 투자자들의 관심이 증가했다. 이 회사는 3분기 주당 6.13달러의 이익과 56억 5천만 달러의 매출을 기록했으며, 이는 월스트리트 컨센서스 예상을 초과한 결과이다. 리인슈런스 그룹의 3분기는 기록적인 재무 결과를 기록했다. 이 강력한 분기는 주식이 향후 성장 기회에 대한 투자자들의 레이더에 오르는 데 도움이 될 수 있다.
주가는 금요일 1.90% 상승한 215.10달러에 마감되었다. 지난 5일 동안 1.37% 상승했으며, 2024년 연초 대비 31.83% 상승했다.
<img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01143928/Screenshot-230.png?optimize=medium&amp;dpr=1.25&amp;auto=webp&amp;width=2048" />
세라 프로그노스틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERA#NASDAQ">SERA</a>):
3분기 재무 결과를 11월 6일에 발표할 예정이다. 이 회사는 임신 조기 출산 테스트를 위한 PreTRM 테스트를 개발했다. 투자자 발표에서는 이 회사의 미래 제품 파이프라인에 대한 설명도 있었으며, 예측 분석 제품과 출산 시기 테스트가 포함될 예정이다.
이 임신 진단 회사의 주가는 금요일 1.56% 상승한 7.81달러에 마감되었다. 지난 5거래일 동안 16.57% 상승했다. 2024년 연초 대비 30.82% 상승했다.
다음 주 보고서를 계속 지켜봐 주시기 바랍니다. 여기에서 Benzinga Pro를 팔로우하여 모든 최신 헤드라인과 <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent102524&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">시장을 움직이는 주요 스토리</a>를 확인하세요.
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요. 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Sera Prognostics

뉴스

에 대한 최신 뉴스 Sera Prognostics (NASDAQ:SERA) 주식

토요일, 11월 02, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌